Daniel Patrick O'Day sold $1.0M of Gilead Sciences (GILD)

Executed Jun 30 2025, disclosed Jul 1 2025, 1 day later.

Value, as filed

$1.0M

9,400 sh × $110.40

Executed

Jun 30 2025

the trade date, as filed

Disclosed

Jul 1 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel Patrick O'Day Chairman & CEO profile →

Daniel Patrick O'Day (Chairman & CEO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $17.3M of GILD (115,640 sh × $150.00, as filed), executed Feb 5.

The name

GILD

Gilead Sciences, Inc. GILD · Healthcare · 86 filings in 24 months ticker →

Healthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Patrick O'Day in GILD

GILDSALE Gilead Sciences, Inc. $2.2M
15,000 sh across 3 lots
Exec Sep 1
Filed Sep 2 · 4:12 PM ET GILDSALE Gilead Sciences, Inc. $1.9M
14,400 sh across 2 lots
Exec Aug 3
Filed Aug 4 · 5:40 PM ET GILDSALE Gilead Sciences, Inc. $1.9M
15,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 4:14 PM ET GILDSALE Gilead Sciences, Inc. $2.0M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $1.3M
10,000 sh across 2 lots
Exec Apr 28
Filed Apr 29 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $1.4M
10,000 sh × $136.82
Exec Mar 27
Filed Mar 30 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $1.4M
9,900 sh across 2 lots
Exec Feb 27
Filed Mar 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $17.3M
115,640 sh × $150.00
Exec Feb 5
Filed Feb 6 · 5:30 PM ET